ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

VNDA Vanda Pharmaceuticals Inc

4.19
0.30 (7.71%)
Mar 28 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 1,372,202
Bid Price 4.11
Ask Price 4.19
News -
Day High 4.19

Low
3.295

52 Week Range

High
7.00

Day Low 3.91
Company Name Stock Ticker Symbol Market Type
Vanda Pharmaceuticals Inc VNDA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.30 7.71% 4.19 19:49:03
Open Price Low Price High Price Close Price Prev Close
3.92 3.91 4.19 4.11 3.89
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
7,622 1,372,202 $ 4.07 $ 5,591,223 - 3.295 - 7.00
Last Trade Time Type Quantity Stock Price Currency
19:55:28 8 $ 4.18 USD

Vanda Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
236.48M 57.54M - 192.64M 2.51M 0.04 94.27
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Vanda Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No VNDA Message Board. Create One! See More Posts on VNDA Message Board See More Message Board Posts

Historical VNDA Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week3.854.193.793.89678,9870.348.83%
1 Month4.564.7153.713.98868,539-0.37-8.11%
3 Months4.334.763.464.00952,476-0.14-3.23%
6 Months4.624.763.2954.01930,741-0.43-9.31%
1 Year6.827.003.2954.75896,267-2.63-38.56%
3 Years15.2721.86273.2958.85627,309-11.08-72.56%
5 Years18.3921.86273.29510.62617,022-14.20-77.22%

Vanda Pharmaceuticals Description

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improves the lives of patients. Its commercial portfolio comprises two products, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) and nighttime sleep disturbances in Smith-Magenis Syndrome (SMS) and Fanapt for the treatment of schizophrenia. Its other products include Tradipitant (VLY-686), VTR-297, and VQW-765.

Your Recent History

Delayed Upgrade Clock